恒瑞医药：公司收到关于HRS-8364片的《药物临床试验批准通知书》

Group 1 - The core point of the article is that Heng Rui Medicine has received approval from the National Medical Products Administration for the clinical trial of HRS-8364 tablets, which will commence shortly [1] Group 2 - The announcement was made on the evening of November 25, indicating a significant step in the company's drug development process [1] - The approval for the clinical trial is a positive development for Heng Rui Medicine, potentially enhancing its product pipeline and market position [1]